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Background: Autologous chondrocyte transplantation (ACT) is the most commonly
used cell-based surgical procedure for repair of articular cartilage defects. The chal-
lenges of this technique include dedifferentiation of chondrocytes following several
in vitro passages, invasive means of transplantation, and inadequate cell retention lead-
ing to washout of transplanted cells. To overcome these obstacles, we developed a novel
technique of transplanting high-density chondrocyte pellets seeded on a prefabricated,
resorbable, rigid, 2-dimensional template amenable to minimally invasive implantation.
Methods: Chondrocytes were obtained from the costal cartilage of New Zealand white
rabbits and expanded in vitro in monolayer culture. After 2 passages, chondrocyte sus-
pension was centrifuged and a total of 1 × 106 cells condensed on the surface of a
prefabricated, resorbable template of LactoSorb plate (0.5-mm thick, 4-mm diameter).
The construct was incubated for 24 hours in a culture medium before transplantation
into circular 4-mm diameter, 0.5-mm deep defects in a non–weight-bearing part of the
femoral condyle. Control defects were left empty or implanted with LactoSorb alone.
Macroscopic and histological evaluation was performed 4 weeks posttransplantation.
Results: Macroscopically, boundaries of all defects were demarcated and distinguish-
able from adjacent intact cartilage. Regenerative tissue in experimental group appeared
white, smooth, and uniform showing more resemblance to hyaline cartilage. Control
groups revealed absent cartilaginous tissue and defects were ﬁlled with soft, ﬁbrous tis-
sue with an irregular surface. Histologically, the repair tissue in the control groups was
ﬁbroinﬂammatory with irregular surface and no evidence of continuous chondrocytic
regeneration. Cartilage regeneration in the experimental defects revealed a continuous,
high-density layer of chondrocytes surrounding the LactoSorb plates. Consistently with
chondrocyte pellets grown for 4 weeks only, the amount of extracellular matrix depo-
sition in the transplanted group was less than the normal cartilage. Conclusion: We
have developed a novel approach for ACT, utilizing high-density chondrocyte pellets
seeded on a prefabricated, rigid, 2-dimensional resorbable carrier. Our study can serve
as a model for further minimally invasive development of this technique and evaluating
its potential role as an alternative in ACT.
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Articular cartilage defects have limited regenerative capacity. Inadequate repair of
articular cartilage defects after traumatic injury or in degenerative conditions may lead to
osteoarthritis.1,2 Full-thickness cartilage injuries penetrating the subchondral bone lead to
the migration of chondroprogenitor cells to the site of injury and formation of a stable
ﬁbrocartilage repair tissue. On the other hand, the reparative process in partial-thickness
cartilage injuries, conﬁned to the avascular cartilage layer, is poor because of the inability
of the bone marrow cells to enter the defect and the limited migration and contribution of
the neighboring chondrocytes to repair the cartilage defect.3,4
Autologous chondrocyte transplantation (ACT) is the most common cell-based pro-
cedure for repair of cartilage defects. The most widely used approach to this procedure
involves transplantation of culture-expanded autologous chondrocyte suspension into a
reservoir created by ﬁxing a periosteal ﬂap or collagen sheet to the surrounding carti-
lage. It has produced hyaline-like repair tissue in experimental models5−7 and achieved a
widespread clinical use.8−13 However, obtaining sufﬁcient number of differentiated chon-
drocytes (eg, [2–5] × 106 cells) 5,7,8 is a major problem because these cells dedifferentiate
rapidly during multiple passages in monolayer cultures.14−17 Other challenges include in-
efﬁcient cell retention leading to loss of cells into the joint space, limitations in defect
size and geometry, the need for an intact cartilage rim adjacent to the defect, disruption of
the adjacent cartilage as a result of suturing the periosteal ﬂap,5 and invasive implantation
of chondrocytes under a periosteal ﬂap requiring open knee operation with major postop-
erative morbidity. Similarly, perhaps because of microenvironment changes in pH during
resorbable scaffold hydrolysis, chondrocytes seeded in porous matrices have undergone
dedifferentiation with loss of shape and phenotype.18
High-density cultures have been widely used as in vitro model to study embryonic
cartilage formation. By supporting cell-cell interactions, high-density cultures have been
shown to promote chondrogenic differentiation.19,20 Dedifferentiated chondrocytes from
monolayer passages (P1–P4) have been shown to regain their chondrocyte phenotype and
form cartilage nodules when grown in pellets.21 In the pellet, the close spatial relationship
of neighboring chondrocytes provides a better environment for cell-cell and cell-matrix
communication, maintaining chondrocyte differentiation.22,23
To address several problems associated with autologous chondrocyte implantation, we
designed a technique suitable for minimally invasive approach, allowing for the implanta-
tion of autologous chondrocyte pellets seeded on, or encapsulated in, a rigid, smooth, and
resorbable carrier of poly-L-lactic acid (PLLA) and polyglycolic acid (PGA), commercially
available as LactoSorb. We have previously shown that cartilaginous constructs enclosed
in a resorbable template of LactoSorb retain their viability and shape.24 The current study
evaluates the feasibility of LactoSorb as a carrier of high-density pellets of chondrocytes
for transplantation of cultured autologous chondrocytes on LactoSorb molded to ﬁt the
size and shape of the chondral defect. The resorbable ﬁxation systems have been clinically
availablesince 1996 and extensivelyutilizedin pediatriccraniofacialﬁxation.25 Their basic
composition consists of a copolymer of PLLA and PGA, which is degraded by hydrolysis
intolacticacidandglycolicacid.26,27 CommerciallyavailableresorbablematerialsMacroP-
ore (MacroPore Biosurgery, Inc, Kensey Nash, Exton, Pa), PolyMax (Synthes, Westchester,
Pa), and LactoSorb (Biomet, Inc, Warsaw, Ind) have numerous compositions, differing
mostly by the degradation speed. We selected LactoSorb because of the shortest resorption
time of less than 12 months.
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MATERIALS AND METHODS
Animals
All animal procedures were approved by the Harvard Medical Area Standing Committee
on Animals. Six-month-old, skeletally matured New Zealand white rabbits weighing 3 kg
were allowed to acclimatize for 1 week before starting the experiment. They were kept
separately in smooth-walled stainless-steel cages, 1 animal per cage, with food and water
ad libitum.
Harvesting and culturing the chondrocytes
We obtained the chondrocytes from the cartilaginous parts of ribs 5 to 8. Skeletally mature
New Zealand white rabbits were anesthetized using intramuscular injection of xylazine
(5 mg/kg of body weight) and ketamine (45 mg/kg of body weight). Costal cartilage was
chosen as a source of chondrocytes for 2 reasons: abundance of released cells leading to
shorter culture time and to avoid violence of articular cartilage prior to the chondrocyte
transplantation.Afterpreppinganddrapingtheanteriorchestinasterilefashion,midsternal
skin incision was performed and the right pectoralis muscle was released from its sternal
origin and reﬂected laterally to expose the costal cartilages. Meticulous attention was paid
not to damage the parietal pleura. Hemostasis was achieved and incision was closed in
layers.
Afterremovingtheperichondriumundersterileconditions,theharvestedcartilagewas
sliced into 1-mm pieces, washed 3 times in sterile phosphate-buffered saline containing
100 units/mL of penicillin, 100 μg/mL of streptomycin (GIBCO; Invitrogen, Grand Island,
NY), and 0.25 μg/mL of amphotericin B (Bristol-Myers Squibb, Princeton, NJ), and
digestedfor18hoursin15mLofDulbecco’sModiﬁedEagle’sMedium(DMEM)containing
0.2% collagenase II (Worthington Biochemical, Freehold, NJ) and antibiotics (as above)
at 37◦Ci na5 %C O 2 incubator. Subsequently, 20 mL of DMEM was added and the
resulting chondrocyte suspension was homogenously distributed by repeated pipetting for
10 times. The liberated cells were then passed through a sterile 250-μm nylon mesh ﬁlter
and collected by centrifugation at 1200 rpm for 6 minutes. Ham’s F-12 medium (Hyclone;
Fischer Scientiﬁc, Pittsberg, Pa) supplemented with 10% fetal bovine serum, 100 units/mL
of penicillin, 100 μg/mL of streptomycin, 0.25 μg/mL of amphotericin B (Bristol-Myers
Squibb), 50 μg/mL of L-ascorbic acid 2-phosphate Mg (Sigma-Aldrich, St Louis, Mo),
2m Mo fL-glutamine (Sigma-Aldrich), 1% nonessential amino acids (Sigma-Aldrich), and
5 μgo fT G F - β1 (Sigma-Aldrich) was used for cell culture. The recovered chondrocytes
were resuspended in 20 mL of culture medium and homogenized by repeated pipetting
for 20 times. An aliquot of the suspension was exposed to trypan blue (Sigma-Aldrich)
to determine cell viability, and those cells that excluded the dye were counted with a
hemocytometer. The resulting cell suspension was cultured in 100-mm dishes (FALCON;
Becton Dickinson Labware, Wyckoff, NJ) at 37◦Ci na5 %C O 2 incubator. The medium
was changed on day 1 and every 4 days afterward. Upon reaching conﬂuence, 1 × 106
chondrocytes were condensed by centrifugation at 1000 rpm for 5 minutes, forming high-
density pellets of chondrocytes, which were then seeded on LactoSorb and incubated in the
culture medium prior to implantation.
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Figure 1. A cone made from resorbable carrier (A) is used to carry the chondrocyte pellets to
deep cartilage defects (B).
This study was conducted in 2 parts. In the ﬁrst set of experiments, high-density
pellets of chondrocytes were seeded onto LactoSorb, molded as a cone (Fig 1A), and the
resulting construct was incubated for 6 weeks during which time, individual chondrocytes
gained organized structure resembling hyaline cartilage. The construct was then implanted
into the deep cartilage defect (Fig 1B). Rabbits were euthanized after 2 weeks to evaluate
the cartilage repair. This part was done to evaluate the ability of chondrocyte pellets to
maintain their phenotype both in vitro and in vivo after prolonged culturing and to assess
the LactoSorb potential as efﬁcient carriers of chondrocytes.
In the second part of the study, high-density pellets of chondrocytes were seeded on
round LactoSorb plates of 0.5-mm thickness and 4-mm diameter (Fig 2) and incubated for
only 24 hours in the culture medium before transplantation into 0.5-mm deep cartilaginous
defects. This way, transplanted chondrocytes were directly facing the bed of the defect.
328POMAHAC ET AL
Figure 1. (Continued).
In this latter part of the experiments, cells were passed twice before they were condensed
at a density of 1 × 106 onto the surface of LactoSorb plates. Here, the assessment of
repair tissue was done 4 weeks after transplantation. In all experiments, LactoSorb plates
were coated with poly-L-lysin to negatively charge its surface and improve adherence of
cells.
Creation of defect and chondrocyte transplantation
General anesthesia was induced as described. The animals were placed supine on the
operating table and the experimental knee was shaved, prepared, and draped in a sterile
fashion. The knee was entered by a longitudinal medial parapatellar incision and the patella
was dislocated laterally to expose the articular surface of the femoral condyles. A circular
defect, 4-mm in diameter, was created in the patellar groove of the distal femur down to
subchondral bone with a stainless steel punch (Fig 3). The depth was gauged by a mark on
the punch device at 0.5 mm, allowing smooth contouring of the joint by the added thickness
of the LactoSorb. The LactoSorb pellet with cultured chondrocytes on its surface facing the
defect was then implanted. In our experience, the repositioned patella provides adequate
ﬁxation of the carrier in desired position and therefore additional ﬁxation is not necessary.
Incision was closed in a layered fashion. Each rabbit had only 1 knee operated, and a total
of 30 defects were created in 30 rabbits. Our groups were composed of a transplanted
group that received chondrocyte-seeded LactoSorb (n = 10) and 2 control groups, in
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Figure 2. Demonstration of the LactoSorb plates of 0.5-mm thickness and 4-mm diameter before
seeding the chondrocyte pellets on its surface.
which defects were either left empty (n = 6) or ﬁlled with LactoSorb alone (n = 6). The
patella was then reduced and the wound was closed in layers using 5-0 vicryl interrupted
sutures. Postoperatively, the rabbits were returned to their cages and allowed to ambulate
freely.
Evaluation of reparative tissue
Four weeks after transplantation, the animals were euthanized by an overdose injection of
pentobarbital and their chondral defect was inspected for shape, contour, and integration
of reparative tissue with adjacent native cartilage. The specimens were then ﬁxed with
paraformaldehyde, decalciﬁed overnight, embedded in parafﬁn, and sectioned for hema-
toxylin and eosin (H&E) staining.
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Figure 3. A 4-mm diameter circular defect was created in the patellar groove of the distal femur
down to subchondral bone with a stainless steel punch. The depth was gauged by a mark on the
punch device at 0.5 mm, allowing smooth contouring of the joint by the added thickness of the
LactoSorb.
RESULTS
Intheearlyexperimentswithimplantationofcone-shapedLactoSorbconstructscontaining
chondrocyte pellets, chondrocytes seemed to redifferentiate and maintained their chondro-
genic potential for 8 weeks (6 weeks in vitro culturing and 2 weeks in vivo), evidenced by
the formation of hyaline-like cartilage both in gross appearance and in histological sections
in contrast to the control defects (Fig 4).
In the experiments in which round pieces of LactoSorb plates were used as a plat-
form for high-density seeding of chondrocytes, macroscopic examination revealed that the
boundaries of defects in all knees were demarcated and distinguishable from the adja-
cent intact cartilage. In general, the regenerative tissue in the transplanted group appeared
white, smooth, and uniform in texture showing more resemblance to healthy normal hya-
line cartilage (Fig 5A). In the control groups, cartilaginous tissue was generally absent and
the defects were ﬁlled with nonspeciﬁc soft, ﬁbrous tissue with an irregular surface (Fig
5B). Histologically, healing was evaluated by cellular morphology and the presence of a
continuous layer of chondrocytes ﬁlling the defect. At 4 weeks, the chondral defects in
the control groups were ﬁlled with ﬁbrous tissue and none of them showed evidence of
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Figure 4. Knee joint 2 weeks following transplantation of chondrocyte pellet in a cone
of LactoSorb reveals hyaline-like cartilage (A) conﬁrmed histologically (B). The central
white area corresponds to the transplanted chondrocyte pellet. Unhealed control defect at
2 weeks, with partial ﬁbrous repair demonstrated in part C.
332POMAHAC ET AL
Figure 4. (Continued).
full chondrocytic regeneration. Cellular morphology was described as ﬁbrous and inﬂam-
matory in nature (Fig 6A). Surface was not continuously covered with chondrocytes and
was irregular. Cartilage regeneration in the experimental defects was signiﬁcantly superior
compared with that of the control defects revealing a continuous layer of chondrocytes
surrounding the LactoSorb plates the majority of the time, indirectly conﬁrming its origin
333ePlasty VOLUME 9
Figure 4. (Continued).
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Figure 5. Macroscopic appearance of the repair tissue in the transplanted group (A) appeared
white, smooth, and uniform in texture showing more resemblance to healthy normal hyaline
cartilage. In the control groups (B), cartilaginous tissue was generally absent and the defects were
ﬁlled with nonspeciﬁc soft, ﬁbrous tissue with an irregular surface.
from the transplanted pellet (Fig 6B). Consistently with chondrocyte pellets grown for
4 weeks only, the amount of extracellular matrix deposition in the transplanted group was
grossly less than the normal cartilage.
DISCUSSION
Articular cartilage has limited capacity for spontaneous regeneration. Inadequate repair
leads to pain and disability and may result in degenerative arthritis.1,2 Following limited
and short-term success of various marrow-stimulating surgical procedures28−32 in pro-
moting ﬁbrocartilaginous repair in focal cartilage defects and their inferior biomechanical
properties, cell-based treatment modalities were developed to achieve a more durable and
functional cartilage. Autologous chondrocyte transplantation in the treatment of focal ar-
ticular cartilage defects gained popularity in the early 1990s and has achieved a widespread
clinical use.8−13 Following in vitro expansion, the chondrocyte suspension is injected into a
pocket created by suturing a periosteal ﬂap to the surrounding cartilage. Acquisition of suf-
ﬁcient number of chondrocytes that can maintain their differentiated phenotype is a major
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Figure 5. (Continued).
Figure 6. Histological section of the defects 4 weeks after creation. The empty defects (A and
B) are ﬁlled with ﬁbrous repair, with absence of continuous chondrocytic layer bridging the
defect. In a representative experimental defect (C), newly formed cartilage is demonstrated by
a thick and continuous layer of chondrocytes underneath the LactoSorb plate, suggesting its
origin from the transplanted pellet. There is also a continuous layer of chondrocytes above the
LactoSorb plate, likely resulting from migration of transplanted chondrocytes. The untrans-
planted control groups (LactoSorb alone with no chondrocytes) are shown in part D. Here, the
defect is ﬁlled with ﬁbrovascular tissue and there is no evidence of cartilaginous regeneration.
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Figure 6. (Continued).
challenge for this technique and remains unresolved. In addition, it requires an open knee
operation that is associated with major morbidity and lengthy postoperative rehabilitation.
Wide exposure necessary for performing this procedure is one of the major reasons why
this technique has been limited only to the knee joint.
Despiteadvanceincartilagetissueengineeringand3-dimensionalmatrices,thesearch
for an optimal method to enhance cartilage regeneration continues. In this study, we eval-
uated the feasibility of autologous chondrocyte pellets as a regenerative source in the
treatment of focal cartilage defects. High-density cultures promote chondrogenic differen-
tiation of multipotential mesenchymal cells19,20 and enhance chondrocyte phenotype after
multiple passages (P1–P4) in prolonged monolayer chondrocyte culturing.21 In the pellet,
the close spatial relationship of neighboring chondrocytes provides a better environment
for cell-cell and cell-matrix communication, maintaining chondrocyte differentiation.22,23
To deliver the chondrocyte pellets in vivo to focal articular cartilage defects, we used a
novel technique, in which 1 × 106 chondrocytes were condensed on the surface of a re-
sorbable carrier (LactoSorb) that was trimmed to the shape and size of the cartilaginous
defectpriortoimplantation.Weobservedsuperiorcartilageregenerationinthedefectswith
transplanted chondrocytes compared with the untreated defects.
This publication reports our preliminary experience with transplantation of high-
density chondrocytes seeded on resorbable templates of PLLA and PGA—LactoSorb—
to focal articular defects. Our approach has several advantages. Although we used an
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Figure 6. (Continued).
open technique for our experimental transplantation, our technique has minimal-invasive
applicability; the implantation of the plate could be accomplished by arthroscopic or
arthroscopy-assisted techniques, reducing operating time and postoperative rehabilitation.
One of the major challenges of the commonly used ACT procedures is the dedifferentiation
of chondrocytes during multiple-passage monolayer culturing, which is needed to obtain
sufﬁcient numbers of chondrocytes to ﬁll the cartilaginous defects. By promoting redif-
ferentiation of chondrocytes and enhancing their chondrogenic potential, our technique of
transplanting pellets instead of chondrocytic suspensions allows for adequate expansion
of cells prior to transplantation. In addition, our delivery method of using rigid, smooth,
and resorbable LactoSorb templates that are prefabricated to ﬁt the cartilaginous defect
dimensions, with the chondrocyte pellets seeded on its surface, can increase the retention
of cells and minimize their washout, which seems to be a disadvantage of transplanting
chondrocyte suspensions. In the future, the shape and size of the cartilaginous defect could
be obtained from 3-dimensional computed tomographic scan, magnetic resonance imag-
ing,orarthroscopicimprintandchondrocyte-seededcarriermanufacturedcorrespondingly.
Furthermore,therigidityofthiscarriersystemallowsfortransmissionofmechanicalforces
on the transplanted chondrocytes that have been found important for their chondrogenic
phenotype.33−36 It can also be ﬁxed with resorbable screws if needed. Ultimately, the most
useful application of this technique would be a 1-stage harvest and implantation of the
338POMAHAC ET AL
Figure 6. (Continued).
autologous chondrocytes. This advancement would eliminate 1 procedure in the operating
room and the regulatory burden for off-site cell-culturing facilities.
This article reported our novel approach to ACT. We tested the suitability of our
carrier system in delivering high-density chondrocyte pellets to cartilage defects. We have
no intention of claiming superiority of our technique over other methods of ACT because
a more detailed and longer term assessment of its histological and functional outcomes is
required. The limitations of this study included a lack of quantitative analysis of the repair
tissue and a relatively short follow-up. However, our study can serve as a model for further
developments of this technique and evaluating its potential role as an alternative in ACT.
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